Alerte De Sécurité sur (1) A-11, (2) A-15, (3) A (1) A-11, (2) A-15, (3) A -18, (4) A-22, (5) AF-150, (6) AF-180, (7) AF-220, (8) AX-15, (9) AX-22; dialyzer with cellulose acetate fiber series A: (10) Altra Flux, (11) Altra Nova, (12) Altrex, Product codes: (1) 237011, 237311, 237511; (2) 237015, 237315, 237515; (3) 237018, 237318, 237518; (4) 237022; (5) 238015, 238515; (6) 238018, 238518; (7) 238022, 238522; (8) 239015; (9) 239022, 239522; (10 to 12) unidentified; number of lots: (1 to 9) all numbers, (10) 990904P6A1 to 011017P7A, (11) 990924P1D1 to 011019P4A, (12) 990929P6A1 to 000203P6A1; number of catalogs: (1 to 9) unidentified; (10 to 12) 100-416, 100-923, 700-098, 700-150

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par Baxter International Inc.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    385
  • Date
    2001-12-07
  • Pays de l'événement
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    UNTIL THIS DATE DOES NOT CONSERT PRODUCT REGISTRATION IN BRAZIL
  • Cause
    Ecri discussed the current baxter dialysis research on deaths in the united states and abroad. the fda recently issued additional information regarding this correction. in addition to the original models being corrected, baxter is withdrawing its a-11, ax-15 and ax-22 models as a precautionary measure, baxter is redoing the altra flux series a cellulose acetate , altra nova and altrex used in baxter a, af and ax series dialyzers.
  • Action
    Please verify receipt of the dated letter and response form dated October 18, 2001 from Baxter. Identify and isolate all affected products in your inventory. Baxter recommends that you immediately stop using any of the products mentioned above. Complete and return the response form to the following fax number (847) 270-5457. If you have distributed these dialyzers to other establishments, please send the correction letter and the response form to these units immediately. For more information, contact your local representative and visit http://www.baxter.com/customers/cust_svc/index.html to find links specific to your country. Baxter began corrections by telephone and by letter dated October 18, 2001.

Manufacturer

  • Source
    ANVSANVISA